Literature DB >> 16249448

Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells.

Jichun Yang1, Claudia E Robert, Brant R Burkhardt, Robert A Young, Jianmei Wu, Zhiyong Gao, Bryan A Wolf.   

Abstract

Pancreatic-derived factor (PANDER) is an islet-specific cytokine present in both pancreatic alpha- and beta-cells, which, in vitro, induces beta-cell apoptosis of primary islet and cell lines. In this study, we investigated whether PANDER is secreted by pancreatic alpha- and beta-cells and whether PANDER secretion is regulated by glucose and other insulin secretagogues. In mouse-derived insulin-secreting beta-TC3 cells, PANDER secretion in the presence of stimulatory concentrations of glucose was 2.8 +/- 0.4-fold higher (P < 0.05) than without glucose. Insulin secretion was similarly increased by glucose in the same cells. The total concentration of secreted PANDER in the medium was approximately 6-10 ng/ml (0.3-0.5 nmol/l) after a 24-h culture with glucose. L-Glucose failed to stimulate PANDER secretion in beta-TC3 cells. KCl stimulated PANDER secretion 2.1 +/- 0.1-fold compared with control without glucose. An L-type Ca2+ channel inhibitor, nifedipine, completely blocked both glucose- or KCl-induced insulin and PANDER secretion. In rat-derived INS-1 cells, glucose (20 mmol/l) stimulated PANDER secretion 4.4 +/- 0.9-fold, while leucine plus glutamine stimulated 4.4 +/- 0.7-fold compared with control without glucose. In mouse islets overexpressing PANDER, glucose (20 mmol/l) stimulated PANDER secretion 3.2 +/- 0.5-fold (P < 0.05) compared with basal (3 mmol/l glucose). PANDER was also secreted by alpha-TC3 cells but was not stimulated by glucose. Mutations of cysteine 229 or of cysteines 91 and 229 to serine, which may form one disulfide bond, and truncation of the COOH-terminus or NH2-terminus of PANDER all resulted in failure of PANDER secretion, even though these mutant or truncated PANDERs were highly expressed within the cells. In conclusion, we found that 1) PANDER is secreted from both pancreatic alpha- and beta-cells, 2) glucose stimulates PANDER secretion dose dependently in beta-cell lines and primary islets but not in alpha-cells, 3) PANDER is likely cosecreted with insulin via the same regulatory mechanisms, and 4) structure and conformation is vital for PANDER secretion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249448     DOI: 10.2337/diabetes.54.11.3217

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  22 in total

1.  Quantitative proteomic profiling reveals hepatic lipogenesis and liver X receptor activation in the PANDER transgenic model.

Authors:  Mark G Athanason; Whitney A Ratliff; Dale Chaput; Catherine B MarElia; Melanie N Kuehl; Stanley M Stevens; Brant R Burkhardt
Journal:  Mol Cell Endocrinol       Date:  2016-07-07       Impact factor: 4.102

Review 2.  PANcreatic-DERived factor: novel hormone PANDERing to glucose regulation.

Authors:  Camella G Wilson; Claudia E Robert-Cooperman; Brant R Burkhardt
Journal:  FEBS Lett       Date:  2011-06-12       Impact factor: 4.124

3.  GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in βIRKO mice.

Authors:  Dan Kawamori; Jun Shirakawa; Chong Wee Liew; Jiang Hu; Tomoaki Morioka; Alokesh Duttaroy; Bryan Burkey; Rohit N Kulkarni
Journal:  Diabetologia       Date:  2017-05-20       Impact factor: 10.122

4.  Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice.

Authors:  Camella G Wilson; Michael Schupp; Brant R Burkhardt; Jianmei Wu; Robert A Young; Bryan A Wolf
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

5.  Characterization of the expression, localization, and secretion of PANDER in alpha-cells.

Authors:  Jason R Carnegie; Claudia E Robert-Cooperman; Jianmei Wu; Robert A Young; Bryan A Wolf; Brant R Burkhardt
Journal:  Mol Cell Endocrinol       Date:  2010-08-30       Impact factor: 4.102

6.  Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic beta-cell function.

Authors:  Claudia E Robert-Cooperman; Jason R Carnegie; Camella G Wilson; Jichun Yang; Joshua R Cook; Jianmei Wu; Robert A Young; Bryan A Wolf; Brant R Burkhardt
Journal:  Diabetes       Date:  2010-06-21       Impact factor: 9.461

7.  PDX-1 interaction and regulation of the Pancreatic Derived Factor (PANDER, FAM3B) promoter.

Authors:  Brant R Burkhardt; Joshua R Cook; Robert A Young; Bryan A Wolf
Journal:  Biochim Biophys Acta       Date:  2008-07-29

8.  ID2 promotes the expansion and survival of growth-arrested pancreatic beta cells.

Authors:  Hong Hua; Nora Sarvetnick
Journal:  Endocrine       Date:  2008-03-06       Impact factor: 3.633

9.  Cytokines in the Progression of Pancreatic β-Cell Dysfunction.

Authors:  Chunjiong Wang; Youfei Guan; Jichun Yang
Journal:  Int J Endocrinol       Date:  2010-11-14       Impact factor: 3.257

10.  Nifedipine protects INS-1 β-cell from high glucose-induced ER stress and apoptosis.

Authors:  Yao Wang; Lu Gao; Yuan Li; Hong Chen; Zilin Sun
Journal:  Int J Mol Sci       Date:  2011-11-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.